![](/images/general/no_picture/200_user.png)
Mychal James Bradley Gibbens
Examiner (ID: 6474)
Most Active Art Unit | 2662 |
Art Unit(s) | 2662 |
Total Applications | 2 |
Issued Applications | 2 |
Pending Applications | 0 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11823185
[patent_doc_number] => 20170212120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'SELECTED REACTION MONITORING ASSAYS'
[patent_app_type] => utility
[patent_app_number] => 15/476118
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17536
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476118
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/476118 | Selected reaction monitoring assays | Mar 30, 2017 | Issued |
Array
(
[id] => 11742866
[patent_doc_number] => 20170196938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'CARRIER-FREE BIOLOGICALLY-ACTIVE PROTEIN NANOSTRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 15/470169
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 14465
[patent_no_of_claims] => 108
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470169
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470169 | Carrier-free biologically-active protein nanostructures | Mar 26, 2017 | Issued |
Array
(
[id] => 11971196
[patent_doc_number] => 20170275350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods'
[patent_app_type] => utility
[patent_app_number] => 15/470117
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21123
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470117
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470117 | Protease activated receptor-1 (PAR1) derived cytoprotective polypeptides and related methods | Mar 26, 2017 | Issued |
Array
(
[id] => 13968305
[patent_doc_number] => 10213486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Formulations of diluted amino acid segments and methods for making same
[patent_app_type] => utility
[patent_app_number] => 15/470239
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13877
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470239 | Formulations of diluted amino acid segments and methods for making same | Mar 26, 2017 | Issued |
Array
(
[id] => 11727955
[patent_doc_number] => 20170189398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/467867
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12396
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467867
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/467867 | Methods and compositions for sleep disorders and other disorders | Mar 22, 2017 | Issued |
Array
(
[id] => 14145463
[patent_doc_number] => 10253090
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Hydrolyzed collagen compositions and methods of making thereof
[patent_app_type] => utility
[patent_app_number] => 15/569240
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4979
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569240
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569240 | Hydrolyzed collagen compositions and methods of making thereof | Mar 19, 2017 | Issued |
Array
(
[id] => 16596726
[patent_doc_number] => 20210023257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => CEREBROSPINAL FLUID LEAKAGE OCCLUSION
[patent_app_type] => utility
[patent_app_number] => 16/085803
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085803 | CEREBROSPINAL FLUID LEAKAGE OCCLUSION | Mar 16, 2017 | Abandoned |
Array
(
[id] => 11977619
[patent_doc_number] => 20170281774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'LINACLOTIDE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/461923
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14671
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461923
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/461923 | LINACLOTIDE COMPOSITIONS | Mar 16, 2017 | Abandoned |
Array
(
[id] => 16288803
[patent_doc_number] => 10765625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Knottin-drug conjugates and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 15/458852
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 12562
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458852
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/458852 | Knottin-drug conjugates and methods of using the same | Mar 13, 2017 | Issued |
Array
(
[id] => 18153084
[patent_doc_number] => 11566045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Tumor targeting polypeptide and method of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/562722
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9976
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562722
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/562722 | Tumor targeting polypeptide and method of use thereof | Mar 13, 2017 | Issued |
Array
(
[id] => 12023645
[patent_doc_number] => 20170313745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'INHIBITORS OF HEPATITIS C VIRUS'
[patent_app_type] => utility
[patent_app_number] => 15/455508
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52232
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455508
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/455508 | INHIBITORS OF HEPATITIS C VIRUS | Mar 9, 2017 | Abandoned |
Array
(
[id] => 16042935
[patent_doc_number] => 10683326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Crystalline salt forms
[patent_app_type] => utility
[patent_app_number] => 16/084168
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 25022
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084168
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084168 | Crystalline salt forms | Mar 9, 2017 | Issued |
Array
(
[id] => 14043477
[patent_doc_number] => 20190077845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => METHODS OF PURIFYING COLLAGEN 7
[patent_app_type] => utility
[patent_app_number] => 16/084998
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084998
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084998 | Methods of purifying collagen 7 | Mar 9, 2017 | Issued |
Array
(
[id] => 14143157
[patent_doc_number] => 10251930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Treatment of degenerative joint disease
[patent_app_type] => utility
[patent_app_number] => 15/453573
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8995
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453573
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/453573 | Treatment of degenerative joint disease | Mar 7, 2017 | Issued |
Array
(
[id] => 13805287
[patent_doc_number] => 10179905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-15
[patent_title] => Factor VII conjugates
[patent_app_type] => utility
[patent_app_number] => 15/453188
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 15290
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453188
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/453188 | Factor VII conjugates | Mar 7, 2017 | Issued |
Array
(
[id] => 13263353
[patent_doc_number] => 10143746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-04
[patent_title] => Immunomodulators
[patent_app_type] => utility
[patent_app_number] => 15/446298
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45416
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15446298
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/446298 | Immunomodulators | Feb 28, 2017 | Issued |
Array
(
[id] => 11969892
[patent_doc_number] => 20170274047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1. 3 POTASSIUM CHANNELS'
[patent_app_type] => utility
[patent_app_number] => 15/445423
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12634
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15445423
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/445423 | ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1. 3 POTASSIUM CHANNELS | Feb 27, 2017 | Abandoned |
Array
(
[id] => 11707954
[patent_doc_number] => 20170176452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'THYROGLOBULIN QUANTITATION BY MASS SPECTROSCOPY'
[patent_app_type] => utility
[patent_app_number] => 15/443805
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10598
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443805
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/443805 | Thyroglobulin quantitation by mass spectroscopy | Feb 26, 2017 | Issued |
Array
(
[id] => 11707952
[patent_doc_number] => 20170176451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'KISSPEPTIN-54 DETECTION BY TANDEM MASS SPECTROMETRY'
[patent_app_type] => utility
[patent_app_number] => 15/443645
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12471
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/443645 | Kisspeptin-54 detection by tandem mass spectrometry | Feb 26, 2017 | Issued |
Array
(
[id] => 14338891
[patent_doc_number] => 20190151418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => COMBINATION OF CALCIUM-PHOSPHATE-CONTAINING POROUS COMPOSITE AND PTH
[patent_app_type] => utility
[patent_app_number] => 16/091632
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091632
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091632 | COMBINATION OF CALCIUM-PHOSPHATE-CONTAINING POROUS COMPOSITE AND PTH | Feb 23, 2017 | Abandoned |